PL365154A1 - Kompozycje farmaceutyczne zawierające tobramycynęi gumę ksantanową - Google Patents

Kompozycje farmaceutyczne zawierające tobramycynęi gumę ksantanową

Info

Publication number
PL365154A1
PL365154A1 PL01365154A PL36515401A PL365154A1 PL 365154 A1 PL365154 A1 PL 365154A1 PL 01365154 A PL01365154 A PL 01365154A PL 36515401 A PL36515401 A PL 36515401A PL 365154 A1 PL365154 A1 PL 365154A1
Authority
PL
Poland
Prior art keywords
xanthan gum
compositions containing
pharmaceutical compositions
tobramycin
containing tobramycin
Prior art date
Application number
PL01365154A
Other languages
English (en)
Other versions
PL199321B1 (pl
Inventor
Perdiguer Nuria Carreras
Mas Jose Alberto Vallet
Cabello Gemma Torrella
Original Assignee
Alcon Inc.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Alcon Inc. filed Critical Alcon Inc.
Publication of PL365154A1 publication Critical patent/PL365154A1/pl
Publication of PL199321B1 publication Critical patent/PL199321B1/pl

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7028—Compounds having saccharide radicals attached to non-saccharide compounds by glycosidic linkages
    • A61K31/7034—Compounds having saccharide radicals attached to non-saccharide compounds by glycosidic linkages attached to a carbocyclic compound, e.g. phloridzin
    • A61K31/7036—Compounds having saccharide radicals attached to non-saccharide compounds by glycosidic linkages attached to a carbocyclic compound, e.g. phloridzin having at least one amino group directly attached to the carbocyclic ring, e.g. streptomycin, gentamycin, amikacin, validamycin, fortimicins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/36—Polysaccharides; Derivatives thereof, e.g. gums, starch, alginate, dextrin, hyaluronic acid, chitosan, inulin, agar or pectin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/44—Oils, fats or waxes according to two or more groups of A61K47/02-A61K47/42; Natural or modified natural oils, fats or waxes, e.g. castor oil, polyethoxylated castor oil, montan wax, lignite, shellac, rosin, beeswax or lanolin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0014—Skin, i.e. galenical aspects of topical compositions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0043—Nose
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0048—Eye, e.g. artificial tears
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Ophthalmology & Optometry (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Molecular Biology (AREA)
  • Dermatology (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Inorganic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Otolaryngology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
PL365154A 2000-07-28 2001-06-26 Kompozycje farmaceutyczne zawierające tobramycynę i gumę ksantanową PL199321B1 (pl)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US22166000P 2000-07-28 2000-07-28
PCT/EP2001/007267 WO2002009724A1 (en) 2000-07-28 2001-06-26 Pharmaceutical compositions containing tobramycin and xanthan gum

Publications (2)

Publication Number Publication Date
PL365154A1 true PL365154A1 (pl) 2004-12-27
PL199321B1 PL199321B1 (pl) 2008-09-30

Family

ID=22828757

Family Applications (1)

Application Number Title Priority Date Filing Date
PL365154A PL199321B1 (pl) 2000-07-28 2001-06-26 Kompozycje farmaceutyczne zawierające tobramycynę i gumę ksantanową

Country Status (18)

Country Link
US (1) US6352978B1 (pl)
EP (1) EP1305033B1 (pl)
CN (1) CN1218689C (pl)
AR (1) AR029965A1 (pl)
AT (1) ATE279927T1 (pl)
AU (1) AU2001270593A1 (pl)
BR (1) BR0112787B1 (pl)
CA (1) CA2414737C (pl)
CO (1) CO5300418A1 (pl)
DE (1) DE60106619T2 (pl)
DK (1) DK1305033T3 (pl)
ES (1) ES2225573T3 (pl)
MX (1) MXPA03000813A (pl)
PL (1) PL199321B1 (pl)
PT (1) PT1305033E (pl)
TW (1) TWI282278B (pl)
WO (1) WO2002009724A1 (pl)
ZA (1) ZA200300110B (pl)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR101301839B1 (ko) * 2004-09-28 2013-08-29 센주 세이야꾸 가부시키가이샤 잔탄 검 및 아미노산을 함유하는 안과용 조성물
US7795316B1 (en) 2007-12-19 2010-09-14 Alcon Research, Ltd. Topical ophthalmic compositions containing tobramycin and dexamethasone
TWI544934B (zh) * 2008-06-09 2016-08-11 愛爾康研究有限公司 含有氟喹諾酮抗生素藥物之經改良藥學組成物
AU2010356098B2 (en) * 2010-06-23 2014-08-14 Alcon Research, Ltd. Topical ophthalmic suspensions containing tobramycin and dexamethasone
EP2704726B1 (en) 2011-05-04 2018-10-31 Trustees of Boston University Proton-motive force stimulation to potentiate aminoglycoside antibiotics against persistent bacteria

Family Cites Families (49)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3700451A (en) 1970-04-06 1972-10-24 Itek Corp Gelable and gelled compositions
US3944427A (en) 1970-04-06 1976-03-16 Itek Corporation Gelable and gelled compositions
US3784712A (en) 1970-12-23 1974-01-08 Gen Foods Corp Gum gelling system xanthan-tara dessert gel
CA1070629A (en) 1975-11-10 1980-01-29 Allen I. Laskin Process for modifying biopolymers
US4135979A (en) 1976-08-24 1979-01-23 Merck & Co., Inc. Treatment of xanthan gum to improve clarity
US4136173A (en) 1977-01-31 1979-01-23 American Home Products Corp. Mixed xanthan gum and locust beam gum therapeutic compositions
US4136178A (en) 1977-01-31 1979-01-23 American Home Products Corp. Locust bean gum therapeutic compositions
US4136177A (en) 1977-01-31 1979-01-23 American Home Products Corp. Xanthan gum therapeutic compositions
GB8318403D0 (en) 1983-07-07 1983-08-10 Sutherland I W Gel-forming polysaccharides
FR2551087B1 (fr) 1983-08-30 1986-03-21 Rhone Poulenc Spec Chim Procede de traitement d'une solution de polysaccharide et son utilisation
DE3335593A1 (de) 1983-09-30 1985-04-11 Diamalt AG, 8000 München Gelier- und verdickungsmittel auf der basis von cassia-galactomannanen
US4717713A (en) 1983-10-31 1988-01-05 Research Corporation Controlled release liquid pharmaceutical
US4708861A (en) 1984-02-15 1987-11-24 The Liposome Company, Inc. Liposome-gel compositions
FR2588189B1 (fr) 1985-10-03 1988-12-02 Merck Sharp & Dohme Composition pharmaceutique de type a transition de phase liquide-gel
US4647470A (en) 1985-11-27 1987-03-03 Merck & Co., Inc. Low-acetyl gellan gum blends
FR2618333B1 (fr) 1987-07-20 1990-07-13 Merck Sharp & Dohme Composition pharmaceutique et/ou cosmetique a usage topique contenant de la gomme rhamsam
US5192535A (en) 1988-02-08 1993-03-09 Insite Vision Incorporated Ophthalmic suspensions
US4814160A (en) 1988-03-01 1989-03-21 Colgate-Palmolive Company Non-bleeding striped dentifrice
US5446070A (en) 1991-02-27 1995-08-29 Nover Pharmaceuticals, Inc. Compositions and methods for topical administration of pharmaceutically active agents
US5234957A (en) 1991-02-27 1993-08-10 Noven Pharmaceuticals, Inc. Compositions and methods for topical administration of pharmaceutically active agents
US5149694A (en) 1988-03-09 1992-09-22 Alcon Laboratories, Inc. Combination of tobramycin and dexamethasone for topical ophthalmic use
DE3843416A1 (de) 1988-12-23 1990-06-28 Wolff Walsrode Ag Xanthan mit verbesserter loeslichkeit und verfahren zur herstellung
CA2021414C (en) 1989-07-25 2004-09-28 Daniel H. Doherty Genetic control of acetylation and pyruvylation of xanthan gum
US5461081A (en) 1989-09-28 1995-10-24 Alcon Laboratories, Inc. Topical ophthalmic pharmaceutical vehicles
FR2653021A1 (fr) 1989-10-17 1991-04-19 Merck Sharp & Dohme Composition ophtalmique aqueuse liquide a transition de phase liquide-gel.
DK0495421T3 (da) 1991-01-15 1996-12-09 Alcon Lab Inc Anvendelse af carragenaner i topiske ophthalmiske sammensætninger
CA2064160C (en) * 1991-03-27 1998-08-11 Paul J. T. Missel Use of combinations of gelling polysaccharides and finely divided drug carrier substrates in topical ophthalmic compositions
US5212162A (en) 1991-03-27 1993-05-18 Alcon Laboratories, Inc. Use of combinations gelling polysaccharides and finely divided drug carrier substrates in topical ophthalmic compositions
AU2672892A (en) 1991-09-17 1993-04-27 Alcon Laboratories, Inc. Compositions containing quinolone antibiotics and sulfonate of polystyrol
US5192802A (en) 1991-09-25 1993-03-09 Mcneil-Ppc, Inc. Bioadhesive pharmaceutical carrier
US5318780A (en) 1991-10-30 1994-06-07 Mediventures Inc. Medical uses of in situ formed gels
US5473062A (en) 1992-10-29 1995-12-05 Takeda Chemical Industries, Ltd. Process for producing purified xanthan gum
JP3228315B2 (ja) 1993-04-23 2001-11-12 信越化学工業株式会社 キサンタンガムの汚染生菌数を減少させる方法
CA2181048C (en) 1994-01-14 2003-05-06 Lee Shahinian, Jr. A method for sustained and extended corneal analgesia
US5422116A (en) 1994-02-18 1995-06-06 Ciba-Geigy Corporation Liquid ophthalmic sustained release delivery system
EP1125577B1 (en) 1994-04-08 2006-02-15 QLT USA, Inc. Liquid drug delivery compositions
US5523301A (en) 1994-08-05 1996-06-04 Merck & Co., Inc. Optic nerve health
WO1996006597A1 (en) 1994-08-30 1996-03-07 Alcon Laboratories, Inc. Thermally-gelling ophthalmic drug delivery vehicles containing cellulose ethers
US5972326A (en) 1995-04-18 1999-10-26 Galin; Miles A. Controlled release of pharmaceuticals in the anterior chamber of the eye
FR2742336B1 (fr) 1995-12-19 1998-03-06 Chauvin Lab Sa Collyre destine notamment au traitement de l'oeil sec
SE9603480L (sv) 1996-09-23 1998-03-24 Johan Carlfors Beredningsform för svårlösliga läkemedel
FR2754712B1 (fr) 1996-10-17 1999-09-03 Merck Sharp Dohme Chibret Lab Compositions ophtalmiques
US5888493A (en) 1996-12-05 1999-03-30 Sawaya; Assad S. Ophthalmic aqueous gel formulation and related methods
JP2002501533A (ja) 1997-05-30 2002-01-15 メルク エンド カンパニー インコーポレーテッド 高眼圧症治療のための眼科用組成物
KR20010013377A (ko) * 1997-06-04 2001-02-26 데이비드 엠 모이어 마일드한 잔류성 항균 조성물
CA2294343A1 (en) 1997-06-26 1999-01-07 Merck & Co., Inc. Method for optimizing retinal and optic nerve health
US6174524B1 (en) * 1999-03-26 2001-01-16 Alcon Laboratories, Inc. Gelling ophthalmic compositions containing xanthan gum
WO1999051273A1 (en) * 1998-04-07 1999-10-14 Alcon Laboratories, Inc. Gelling ophthalmic compositions containing xanthan gum
US6297337B1 (en) * 1999-05-19 2001-10-02 Pmd Holdings Corp. Bioadhesive polymer compositions

Also Published As

Publication number Publication date
EP1305033A1 (en) 2003-05-02
TWI282278B (en) 2007-06-11
BR0112787B1 (pt) 2013-03-05
ZA200300110B (en) 2004-01-21
DE60106619T2 (de) 2005-03-17
PT1305033E (pt) 2005-01-31
US6352978B1 (en) 2002-03-05
ES2225573T3 (es) 2005-03-16
AU2001270593A1 (en) 2002-02-13
US20020035088A1 (en) 2002-03-21
DE60106619D1 (de) 2004-11-25
PL199321B1 (pl) 2008-09-30
AR029965A1 (es) 2003-07-23
CO5300418A1 (es) 2003-07-31
CN1218689C (zh) 2005-09-14
EP1305033B1 (en) 2004-10-20
CA2414737C (en) 2009-01-06
MXPA03000813A (es) 2005-08-16
ATE279927T1 (de) 2004-11-15
BR0112787A (pt) 2003-09-09
CA2414737A1 (en) 2002-02-07
CN1444482A (zh) 2003-09-24
WO2002009724A1 (en) 2002-02-07
DK1305033T3 (da) 2005-01-31

Similar Documents

Publication Publication Date Title
AU2001279202A1 (en) Compositions containing phosphate and xanthan gum variants
ZA200004413B (en) Gelling ophthalmic compositions containing xanthan gum.
BG106681A (en) Solutions containing epinastine
CA2201749A1 (en) Stable aqueous alfa interferon solution formulations
TR200302105T4 (tr) Siklosporin, hiyalüronik asit ve polisorbat içeren göz formülasyonları.
AU2001233069A1 (en) Pharmaceutical compositions containing anti-beta 1 integrin compounds and uses
IL146789A0 (en) Amorphous nitric esters and their pharmaceutical compositions
BG108009A (en) Complex of modafinil and cyclodextrin
YU8701A (sh) Nova oralna kompozicija
HRP20030002A2 (en) STABLE GABAPENTIN HAVING pH WITHIN A CONTROLLED RANGE
CA2429639A1 (en) Stable azithromycin monohydrate
MXPA03007757A (es) Composiciones que contienen creatina y creatinina.
CA2414737A1 (en) Pharmaceutical compositions containing tobramycin and xanthan gum
WO2001030391A3 (en) Pharmaceutical composition containing midazolam
UY27373A1 (es) Formulaciones de interferón beta-humano
WO2004050123A3 (en) Concentrated liquid valdecoxib composition
AU4929400A (en) Pharmaceutical compositions for oral administration of phloroglucinol and preparation thereof
AU2002311412A1 (en) Thickened aqueous compositions
AU2811400A (en) Stable formulation containing fumagillin
AU4884701A (en) Malonanilic acid derivatives, medicinal compositions containing the same and usethereof
WO2001022917A8 (en) Effervescent compositions comprising nimesulide
AU2002217239A1 (en) Cosmetic or dermo-pharmaceutical compositions containing four o'clock (mirabilis jalapa) plant extracts
AU3903701A (en) Diclofenac pharmaceutical composition based on vitamin-e, papain and hyaluronidase
EP3747443A3 (en) Use of an oestrogen in the manufacture of a composition containing oestrogen for the treatment of atrophic vaginitis
MY126225A (en) Compositions containing creatine and creatinine.